VRTX
Vertex Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
2.70 / 10
Underperform
The technical score of 2.7/10 conveys challenging technical structure. Strengths identified in MACD Death Cross are compromised by deficiencies in MACD Golden Cross, RSI Overbought, and Marubozu White. Technical interpretation: cautious.
Analysis Checks(1/4)
RSI Overbought
Score1/10
Win Rate0.00%
Hist. Signals5
Avg Return-3.03%
Score1/10
Win Rate0.00%
Hist. Signals5
Avg Return-3.03%
MACD Golden Cross
Score1/10
Win Rate33.33%
Hist. Signals15
Avg Return-0.85%
Score1/10
Win Rate33.33%
Hist. Signals15
Avg Return-0.85%
MACD Death Cross
Score7.81/10
Win Rate71.43%
Hist. Signals14
Avg Return0.68%
Score7.81/10
Win Rate71.43%
Hist. Signals14
Avg Return0.68%
Marubozu White
Score1/10
Win Rate11.11%
Hist. Signals9
Avg Return-1.72%
Score1/10
Win Rate11.11%
Hist. Signals9
Avg Return-1.72%
RSI Overbought
Score1/10
Win Rate0.00%
Hist. Signals5
Avg Return-3.03%
Score1/10
Win Rate0.00%
Hist. Signals5
Avg Return-3.03%
MACD Death Cross
Score7.81/10
Win Rate71.43%
Hist. Signals14
Avg Return0.68%
Score7.81/10
Win Rate71.43%
Hist. Signals14
Avg Return0.68%
MACD Golden Cross
Score1/10
Win Rate33.33%
Hist. Signals15
Avg Return-0.85%
Score1/10
Win Rate33.33%
Hist. Signals15
Avg Return-0.85%
Marubozu White
Score1/10
Win Rate11.11%
Hist. Signals9
Avg Return-1.72%
Score1/10
Win Rate11.11%
Hist. Signals9
Avg Return-1.72%
What is the current technical signals for VRTX?
- VRTX presents a Underperform setup with a Technical Score of 2.70/10. Key technical indicators highlight an RSI of 58.14 and a MACD of -0.29, with the trend anchored by the 50-Day SMA at 456.37. Traders should monitor key support at 451.70 and resistance at 471.96.
